Andere talen REGENXBIO Inc.

Aandelen

RGNX

US75901B1070

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 12-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13,15 ^USD	-3,17%		-9,44%	-26,74%

14:09	Regenxbio benoemt Curran Simpson tot president, CEO	MT
14:00	Transcript : REGENXBIO Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:00 AM

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Regenxbio Names Curran Simpson President, CEO	14:09
REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	05/06
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	15/05
REGENXBIO to Participate in Upcoming Investor Conferences	13/05
REGENXBIO to Participate in Upcoming Investor Conferences	10/05
Regenxbio: Q1 Earnings Snapshot	08/05
Earnings Flash (RGNX) REGENXBIO Posts Q1 Revenue $15.6M	08/05
REGENXBIO Inc. Announces Consolidated Impairment Charges for the First Quarter Ended March 31, 2024	08/05
REGENXBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights	01/05
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	24/04
REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition	04/04
One-time gene therapy could improve wet AMD	01/04
REGENXBIO Inc. Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD	28/03
REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days	27/03
REGENXBIO to Participate in Upcoming Investor Conferences	11/03
North American Morning Briefing : Stock Futures -2-	11/03
Regenxbio Insider Sold Shares Worth $365,220, According to a Recent SEC Filing	08/03
REGENXBIO Announces Proposed Public Offering of Common Stock	07/03
North American Morning Briefing : Powell Still in -2-	07/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen REGENXBIO Inc.

Aandelen

RGNX

US75901B1070

Andere talen

Filters